You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Cutaneous Lymphoma

Showing 1 - 25 of 6,841
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Quality of Life in Cutaneous Lymphoma Patients Using Skindex29

Not yet recruiting
  • Cutaneous Lymphoma
  • Quality-of-Life Assessment
  • Questionnaire Administration
  • Duarte, California
    City of Hope Medical Center
Aug 23, 2022

Mycosis Fungoides of Skin (Diagnosis), Cutaneous T-cell Lymphoma, Non Hodgkin Lymphoma Trial in Cleveland (Med-Jet Injector,

Not yet recruiting
  • Mycosis Fungoides of Skin (Diagnosis)
  • +5 more
  • Med-Jet Injector
  • +4 more
  • Cleveland, Ohio
    University Hospitals Cleveland Medical Center, Case Comprehensiv
Jan 17, 2023

Lymphoma, T-Cell, Cutaneous, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Large B-Cell, Diffuse Trial in Spain (Registry of

Recruiting
  • Lymphoma, T-Cell, Cutaneous
  • +5 more
  • Registry of patients (exposure is Cutaneous Lymphoma)
  • Barcelona, Spain
  • +13 more
Mar 15, 2022

Cutaneous T-cell Lymphoma Trial in Beijing (Linperlisib in combined with Chidamide)

Recruiting
  • Cutaneous T-cell Lymphoma
  • Linperlisib in combined with Chidamide
  • Beijing, Beijing, China
    Peking Union Medical College Hospital
Sep 8, 2023

Lymphoma, T-Cell, Cutaneous, Hodgkin Disease, Lymphoma, T-Cell, Peripheral Trial (SGN-35T)

Not yet recruiting
  • Lymphoma, T-Cell, Cutaneous
  • +5 more
  • (no location specified)
Nov 2, 2023

Pediatric Cancer, Hodgkin Disease, CD30-Positive DLBCL Trial in Milwaukee (anti-CD30 Bispecific Antibody-armed

Not yet recruiting
  • Pediatric Cancer
  • +11 more
  • anti-CD30 Bispecific Antibody-armed anti-CD3-Activated Autologous T-cells (CD30 biAb-AATC)
  • Milwaukee, Wisconsin
    Children's Wisconsin
Sep 14, 2022

Cutaneous T-cell Lymphoma Retreated With Brentuximab Vedotin

Not yet recruiting
  • T-Cell Lymphoma
  • No intervention
  • Bordeaux, France
  • +10 more
May 24, 2023

Cutaneous T Cell Lymphoma, Fungoides Mycosis Sezary Syndrome Trial in Ann Arbor (Pembrolizumab, Mogamulizumab)

Not yet recruiting
  • Cutaneous T Cell Lymphoma
  • Fungoides Mycosis Sezary Syndrome
  • Ann Arbor, Michigan
    University of Michigan Comprehensive Cancer Center
Jul 13, 2023

Cutaneous T Cell Lymphoma Trial in Chicago (APR-TD011 (RLF-TD011))

Not yet recruiting
  • Cutaneous T Cell Lymphoma
  • APR-TD011 (RLF-TD011)
  • Chicago, Illinois
    Dermatology CTU
Feb 6, 2023

Remitoro in Recurrent or Refractory Peripheral T Cell Lymphoma

Recruiting
  • Lymphoma, T-cell, Peripheral
  • Lymphoma, T-cell, Cutaneous
  • Nagoya, Japan
  • +2 more
Nov 24, 2022

Folliculotropic Mycosis Fungoides, Recurrent Cutaneous T-Cell Non-Hodgkin Lymphoma, Recurrent Mycosis Fungoides Trial in United

Recruiting
  • Folliculotropic Mycosis Fungoides
  • +7 more
  • Durvalumab
  • +2 more
  • Duarte, California
  • +3 more
Jan 12, 2023

Mogamulizumab in the Treatment of Cutaneous T-cell Lymphoma

Not yet recruiting
  • Cutaneous T Cell Lymphoma
  • +2 more
    • Ancona, Italy
    • +19 more
    Nov 2, 2023

    Cutaneous T Cell Lymphoma, Peripheral T Cell Lymphoma Trial in Boston (Microdevices, Standard of care therapy, Standard of care

    Recruiting
    • Cutaneous T Cell Lymphoma
    • Peripheral T Cell Lymphoma
    • Microdevices
    • +2 more
    • Boston, Massachusetts
      Dana Farber Cancer Institute
    Jul 16, 2022

    T-Cell Lymphoma Trial (Brentuximab vedotin)

    Not yet recruiting
    • T-Cell Lymphoma
    • Brentuximab vedotin
    • (no location specified)
    Jun 30, 2022

    Skin Barrier and Microbiome of CTCL Patients

    Not yet recruiting
    • Lymphoma, T-Cell, Cutaneous
      • Leiden, Netherlands
        Centre for Human Drug Research
      Apr 21, 2023

      T-cell Lymphoma, Cutaneous/Peripheral T-Cell Lymphoma, Peripheral T-cell Lymphoma Trial in Chicago (Fenretinide)

      Not yet recruiting
      • T-cell Lymphoma
      • +10 more
      • Chicago, Illinois
        Rush University Medical Center
      Oct 24, 2022

      Advanced Solid Tumor, Cutaneous T-cell Lymphoma (CTCL) Trial in United States (SIM1811-03)

      Recruiting
      • Advanced Solid Tumor
      • Cutaneous T-cell Lymphoma (CTCL)
      • Detroit, Michigan
      • +5 more
      Oct 6, 2022

      Lymphoma, T-Cell, Cutaneous, Mycosis Fungoides/Sezary Syndrome Trial in Madrid, Zürich (Atezolizumab)

      Active, not recruiting
      • Lymphoma, T-Cell, Cutaneous
      • Mycosis Fungoides/Sezary Syndrome
      • Madrid, Spain
      • +1 more
      Jul 1, 2022

      Cutaneous T-Cell Lymphoma/Mycosis Fungoides Trial in Fairport (Hypericin)

      Completed
      • Cutaneous T-Cell Lymphoma/Mycosis Fungoides
      • Fairport, New York
        Rochester Skin Lymphoma Medical Group
      Aug 24, 2022

      Mycosis Fungoides Trial in Edmonton (Cemiplimab)

      Not yet recruiting
      • Mycosis Fungoides
      • Edmonton, Alberta, Canada
        Cross Cancer Institute
      Sep 12, 2022

      Recurrent Adult T-Cell Leukemia/Lymphoma, Recurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma, Refractory Adult T-Cell

      Recruiting
      • Recurrent Adult T-Cell Leukemia/Lymphoma
      • +3 more
      • Columbus, Ohio
        Ohio State University Comprehensive Cancer Center
      Nov 18, 2022

      Cutaneous T-Cell Lymphoma/Mycosis Fungoides Trial in Fairport (Hypericin, Mechlorethamine Topical Gel)

      Not yet recruiting
      • Cutaneous T-Cell Lymphoma/Mycosis Fungoides
      • Fairport, New York
        Rochester Skin Lymphoma Medical Group
      Nov 20, 2023

      Mycoses, Sezary Syndrome, Lymphoma, T-Cell, Cutaneous Trial in Stanford (anti-thymocyte globulin, cyclosporine, Lymphoid

      Active, not recruiting
      • Mycoses
      • +5 more
      • anti-thymocyte globulin
      • +2 more
      • Stanford, California
        Stanford University School of Medicine
      Jun 16, 2022

      Cutaneous T Cell Lymphoma Trial in Pittsburgh (Micro needle array-Doxorubicin (MNA-D))

      Recruiting
      • Cutaneous T Cell Lymphoma
      • Micro needle array-Doxorubicin (MNA-D)
      • Pittsburgh, Pennsylvania
        University Of Pittsburgh Medical Center
      Jun 2, 2022

      Cutaneous T Cell Lymphoma, Mycosis Fungoides Trial (Hypericin, Visible Light)

      Not yet recruiting
      • Cutaneous T Cell Lymphoma
      • Mycosis Fungoides
      • (no location specified)
      May 23, 2023